Login / Signup

Polysomnographic features associated with clonazepam and melatonin treatment in isolated REM sleep behavior disorder: Time for new therapeutic approaches?

Maria Paola MogaveroRaffaele FerriSara MarelliGiuseppe LanzaMichele TerzaghiAlessandra CastelnuovoLourdes M DelRossoCarlos H SchenckLuigi Ferini Strambi
Published in: CNS neuroscience & therapeutics (2024)
These results suggest that the administration of MLT or CLO impacts (positively) on sleep parameters of iRBD patients. However, there is a need to better stratify patients, in order to treat them in a targeted manner, depending on the patient's individual sleep architecture and expected differential effects of these agents.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • physical activity
  • sleep quality
  • peritoneal dialysis
  • drug delivery
  • patient reported outcomes
  • case report